Seoul, South Korea

Chin Hee Mun

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Good T Cells, Inc.. Active years: 2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Chin Hee Mun. Retrieved from https://idiyas.com/inventor/chin-hee-mun

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovating Autoimmune Disease Treatments: The Contributions of Chin Hee Mun

Introduction: Chin Hee Mun, an accomplished inventor based in Seoul, South Korea, is making significant strides in the field of autoimmune disease treatment. With a focus on innovative compositions and fusion proteins, Mun aims to enhance therapeutic options for conditions such as lupus nephritis and rheumatoid arthritis.

Latest Patents: Chin Hee Mun holds a patent for a "Composition containing SMAD protein for treatment of autoimmune diseases." This invention encompasses a fusion protein comprising SMAD protein, an expression vector, and a method for preparing the composition. His work stands out as a promising avenue for the prevention and treatment of various autoimmune diseases.

Career Highlights: Currently, Chin Hee Mun is contributing his expertise at Good T Cells, Inc. His groundbreaking research is paving the way for new therapeutic strategies, linking his background in innovative medicine with real-world applications.

Collaborations: Throughout his career, Mun has worked alongside distinguished colleagues such as Sang-Kyou Lee and Sung-Dong Park. Together, they are advancing the understanding and treatment of complex autoimmune disorders, highlighting the collaborative spirit of scientific research.

Conclusion: Chin Hee Mun's contributions to the field of autoimmune disease treatment reflect his dedication to innovation and research. With his patent and ongoing work at Good T Cells, Inc., Mun is a leading figure in developing future therapies that promise to enhance patient outcomes and improve quality of life.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…